Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Salim Syed Downgraded (ATRA) to Hold and Decreased Target to $25 on, Nov 9th, 2023
Salim Syed of Mizuho, Downgraded "Atara Biotherapeutics, Inc." (ATRA) to Hold and Decreased Target from $775 to $25 on, Nov 9th, 2023.
Salim has made no other calls on ATRA in the last 4 months.
There are 2 other peers that have a rating on ATRA. Out of the 2 peers that are also analyzing ATRA, 0 agree with Salim's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Salim
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Sell with Decreased Target to $35 on, Monday, August 21st, 2023
- Anthony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $625 on, Wednesday, August 9th, 2023
